четверг, 24 марта 2016 г.

Impact Of Merck Litigation On Ionis Pharmaceuticals

Impact Of Merck Litigation On Ionis Pharmaceuticals


Ionis has the cash necessary to advance its pipeline, so it is not necessarily reliant upon a verdict with Gilead in order to meet targets. The much watched litigation between Gilead Sciences and Merck appears as though it is rapidly heading towards a jury verdict.



from Biotech News